Dec 29, 2025
119:117
For every 117 shares held, investors received 119. The price per share adjusted from $0.09 to $0.08.
The split itself did not change the total investment value.
Neurizon Therapeutics Limited (ASX:NUZ) operates in the Pharmaceuticals: major industry.
Neurizon Therapeutics Limited company overviewNeurizon Therapeutics Limited's most recent stock split was on December 29, 2025. It was a 119-for-117 forward split, so shareholders received 119 shares for every 117 they held.
Neurizon Therapeutics Limited (ASX:NUZ) has split its stock 6 times: a 1-for-5 reverse split on November 15, 2004, a 8-for-7 split on September 17, 2007, a 1-for-20 reverse split on October 30, 2015, a 27-for-26 split on November 10, 2016, a 259-for-235 split on February 20, 2019, and a 119-for-117 split on December 29, 2025.
Neurizon Therapeutics Limited has split its stock 6 times. This history records 6 splits between November 15, 2004 and December 29, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Neurizon Therapeutics Limited's 119-for-117 split on December 29, 2025, every 117 shares became 119 shares.
Neurizon Therapeutics Limited has not announced a new split in our records. Its most recent split was on December 29, 2025, less than a year ago. Companies announce splits in advance, and any new ASX:NUZ split will appear on this page.
Already premium?